Overview

A Dose-response Trial Using rFSH FE 999049 in Women Undergoing IVF/ICSI Treatment

Status:
Completed
Trial end date:
2013-03-01
Target enrollment:
Participant gender:
Summary
This trial investigates the effects of several doses of FE 999049 in women undergoing IVF/ICSI (in-vitro fertilisation/intracytoplasmic sperm injection) treatment.
Phase:
Phase 2
Details
Lead Sponsor:
Ferring Pharmaceuticals